Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04789317 · ClinicalTrials.gov registry record

Pullback Pressure Gradient (PPG) Global Registry

A clinical trial of Chronic Coronary Insufficiency and Non ST Elevation Myocardial Infarction, sponsored by VZW Cardiovascular Research Center Aalst.

Active
Registry status
982
Enrollment target
20
Study locations

NCT04789317 is a study of Chronic Coronary Insufficiency and Non ST Elevation Myocardial Infarction that is active but no longer recruiting, run by VZW Cardiovascular Research Center Aalst. The registered enrollment target is 982 participants. The trial reports 20 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04789317, a study of Chronic Coronary Insufficiency and Non ST Elevation Myocardial Infarction, is active but no longer recruiting, sponsored by VZW Cardiovascular Research Center Aalst.

ACTIVE NOT RECRUITING
Registry status
982 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to determine the predictive capacity of the Pullback Pressure Gradient (PPG) index for post-PCI FFR and to determine the impact of the PPG index on clinical decision making about revascularization and on clinical outcomes.

Study Locations (20)

Other

  • Monash Medical Center - Melbourne
  • Concord Repatriation General Hospital - Sydney
  • OLV Aalst - Aalst
  • Aalborg University Hospital - Aalborg
  • Aarhus University Hospital - Aarhus
  • Righospitalet - Copenhagen
  • Institut Arnault Tzanck - Nice
  • Ferrara University - Ferrara
  • Fondazione Policlinico Universitario A. Gemelli IRCCS - Rome
  • Aichi University - Aichi
  • Gifu Heart Center - Gifu
  • Showa University Hospital - Tokyo
  • Tokyo D Tower Hospital - Tokyo
  • Catharina Ziekenhuis - Eindhoven
  • Radboud UMC - Nijmegen
  • Hospital Clinico San Carlos - Madrid
  • Hospital Universitario de La Princesa - Madrid

California

  • Stanford University - Stanford

New York

  • St Francis Hospital and Heart Center - New York

Texas

  • Memorial Hermann Texas Medical Center - Texas City

Trial Details

FieldValue
Enrollment Target 982 participants
Start Date 2020-12-23
Est. Completion 2026-12-31

What the Registry Record Tells You About NCT04789317

The ClinicalTrials.gov registry entry for NCT04789317 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 982 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VZW Cardiovascular Research Center Aalst, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Chronic Coronary Insufficiency appearing as the primary indexed condition, and to 0 interventions.

NCT04789317 reports 20 study locations spanning 4 distinct geographic areas - top geographies include Other, California, New York.

Frequently Asked Questions

What is clinical trial NCT04789317 about?

NCT04789317 is a clinical study titled "Pullback Pressure Gradient (PPG) Global Registry". The purpose of this study is to determine the predictive capacity of the Pullback Pressure Gradient (PPG) index for post-PCI FFR and to determine the impact of the PPG index on clinical decision making about revascularization and on clinical outcomes.

What is the current status of trial NCT04789317?

This trial is currently active not recruiting. The enrollment target is 982 participants. The study started on 2020-12-23. Estimated completion is 2026-12-31.

What conditions does trial NCT04789317 study?

This clinical trial studies the following conditions: Chronic Coronary Insufficiency, Non ST Elevation Myocardial Infarction.

Who is sponsoring clinical trial NCT04789317?

This trial is sponsored by VZW Cardiovascular Research Center Aalst, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04789317 being conducted?

This trial has 20 study locations across California, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.